/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

E

Erik van Werkhoven

Erasmus MC Cancer Institute(NL)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

346

Papers

10.5K

Citations

46

h-index

124

i10-index

Erik van Werkhoven is an academic researcher from Erasmus MC Cancer Institute. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Immunotherapy and Biomarkers & Cancer Cells and Metastasis. The author has an h-index of 46, co-authored 295 publications.

ORCID: 0000-0001-7469-7427

Research Topics

Breast Cancer Treatment Studies Cancer Immunotherapy and Biomarkers Cancer Cells and Metastasis Cancer Treatment and Pharmacology Cancer Genomics and Diagnostics

Papers by this author

works

Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial

2018 · The Lancet Oncology · 421 citations

https://doi.org/10.1016/s1470-2045(18)30570-9

Mette S. van Ramshorst Anna van der Voort Erik van Werkhoven Ingrid A.M. Mandjes

The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

2019 · Nature · 252 citations

https://doi.org/10.1038/s41586-019-1600-x

Daphne van der Velden Louisa R. Hoes Hanneke van der Wijngaart Jade M. van Berge Henegouwen

Adjuvant chemotherapy in small node-negative triple-negative breast cancer

2020 · European Journal of Cancer · 117 citations

https://doi.org/10.1016/j.ejca.2020.04.033

Tessa G. Steenbruggen Erik van Werkhoven Mette S. van Ramshorst Vincent O. Dezentjé

Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study

2020 · Annals of Surgical Oncology · 87 citations

https://doi.org/10.1245/s10434-020-09273-0

Ariane A. van Loevezijn Marieke E. M. van der Noordaa Erik van Werkhoven Claudette E. Loo

Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol

2022 · Breast Cancer Research and Treatment · 69 citations

https://doi.org/10.1007/s10549-022-06545-z

Ariane A. van Loevezijn Marieke E. M. van der Noordaa Marcel P. M. Stokkel Erik van Werkhoven

Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib

2019 · BMC Cancer · 47 citations

https://doi.org/10.1186/s12885-019-6121-3

Rosemarie de Haan Erik van Werkhoven Michel M. van den Heuvel Heike Peulen

Research topics

topics

Breast Cancer Treatment Studies

Cancer Immunotherapy and Biomarkers

Cancer Cells and Metastasis

Cancer Treatment and Pharmacology

Cancer Genomics and Diagnostics

Chat about Author

Papers

Chat

Click to start Chat